On April 3, 2024, TS Nexgen Co., Ltd. closed the transaction. The company announced that it has issued 11,992,619 common shares at an issue price of KRW 542 per share for the gross proceeds of KRW 6,499,999,498. The transaction will include participation from new investor Cisco Bio Investment Fund.